Sunday, 26 December 2010

Oestradiol Benzoate




Oestradiol Benzoate may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oestradiol Benzoate



Estradiol

Estradiol 3-benzoate (a derivative of Estradiol) is reported as an ingredient of Oestradiol Benzoate in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Saturday, 25 December 2010

Guttanotte




Guttanotte may be available in the countries listed below.


Ingredient matches for Guttanotte



Flunitrazepam

Flunitrazepam is reported as an ingredient of Guttanotte in the following countries:


  • Austria

International Drug Name Search

Monday, 20 December 2010

Ketobemidone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02AB01

CAS registry number (Chemical Abstracts Service)

0000469-79-4

Chemical Formula

C15-H21-N-O2

Molecular Weight

247

Therapeutic Category

Opioid analgesic

Chemical Name

1-Propanone, 1-[4-(3-hydroxyphenyl)-1-methyl-4-piperidinyl]-

Foreign Names

  • Cetobemidonum (Latin)
  • Cetobemidon (German)
  • Cétobémidone (French)
  • Ketobemidona (Spanish)

Generic Names

  • Cétobémidone (OS: DCF)
  • Ketobemidone (OS: BAN)
  • Cetobemidon (IS: ASK)
  • Ciba 7115 (IS: Ciba)
  • Hoechst 10720 (IS: Hoechst)
  • K 4710 (IS)
  • Win 1539 (IS)
  • Cetobemidoni hydrochloridum (PH: Ph. Eur. 6)
  • Ketobemidone Hydrochloride (PH: BP 2010, Ph. Eur. 6)

Brand Names

  • Ketogan
    Pfizer, Iceland; Pfizer, Norway


  • Ketogan Novum
    Pfizer, Sweden


  • Ketorax
    Pfizer, Norway

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 13 December 2010

Suboxone


Suboxone is a brand name of buprenorphine/naloxone, approved by the FDA in the following formulation(s):


SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride - tablet; sublingual)



  • Manufacturer: RECKITT BENCKISER

    Approval date: October 8, 2002

    Strength(s): 2MG;0.5MG, 8MG;2MG [RLD]

SUBOXONE (buprenorphine; naloxone - film; sublingual)



  • Manufacturer: RECKITT BENCKISER

    Approval date: August 30, 2010

    Strength(s): 2MG;0.5MG, 8MG;2MG [RLD]

Has a generic version of Suboxone been approved?


No. There is currently no therapeutically equivalent version of Suboxone available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Suboxone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Polyethylene oxide-based films and drug delivery systems made therefrom
    Patent 8,017,150
    Issued: September 13, 2011
    Inventor(s): Yang; Robert K. & Fuisz; Richard C. & Myers; Garry L. & Fuisz; Joseph M.
    Assignee(s): MonoSol Rx, LLC
    The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film.
    Patent expiration dates:

    • September 10, 2023
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • August 30, 2013 - NEW DOSAGE FORM

See also...

  • Suboxone Consumer Information (Drugs.com)
  • Suboxone Consumer Information (Wolters Kluwer)
  • Suboxone Film Consumer Information (Wolters Kluwer)
  • Suboxone Consumer Information (Cerner Multum)
  • Suboxone Advanced Consumer Information (Micromedex)
  • Buprenorphine/Naloxone Consumer Information (Wolters Kluwer)
  • Buprenorphine/Naloxone Film Consumer Information (Wolters Kluwer)
  • Buprenorphine and naloxone Consumer Information (Cerner Multum)
  • Buprenorphine and naloxone Sublingual Advanced Consumer Information (Micromedex)

Friday, 10 December 2010

Calcio 20 Fuerte




Calcio 20 Fuerte may be available in the countries listed below.


Ingredient matches for Calcio 20 Fuerte



Calcium Phosphate

Calcium Phosphate is reported as an ingredient of Calcio 20 Fuerte in the following countries:


  • Spain

Colecalciferol

Colecalciferol is reported as an ingredient of Calcio 20 Fuerte in the following countries:


  • Spain

International Drug Name Search

Thursday, 9 December 2010

Influenza Prophylaxis Medications


Drugs associated with Influenza Prophylaxis

The following drugs and medications are in some way related to, or used in the treatment of Influenza Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Wednesday, 8 December 2010

Prax




In the US, Prax (pramoxine topical) is a member of the drug class topical anesthetics and is used to treat Anal Itching, Pain and Pruritus.

US matches:

  • Prax Lotion

  • Prax topical

Ingredient matches for Prax



Pramocaine

Pramocaine hydrochloride (a derivative of Pramocaine) is reported as an ingredient of Prax in the following countries:


  • United States

International Drug Name Search

Monday, 6 December 2010

Piribedil




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BC08

CAS registry number (Chemical Abstracts Service)

0003605-01-4

Chemical Formula

C16-H18-N4-O2

Molecular Weight

298

Therapeutic Category

Treatment of Parkinson's disease: Dopaminergic

Chemical Name

Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-

Foreign Names

  • Piribedilum (Latin)
  • Piribedil (German)
  • Piribédil (French)
  • Piribedil (Spanish)

Generic Names

  • Piribedil (OS: DCIT)
  • Piribédil (OS: DCF)
  • ET 495 (IS)
  • EU 4200 (IS)
  • Piprazidine (IS)
  • Piribedyl (IS)
  • S 495 (IS)
  • Piribedil methanesulfonate (IS)

Brand Names

  • Clarium
    Desitin, Germany


  • Pronoran
    Servier, Georgia; Servier, Lithuania; Servier, Latvia; Servier, Poland; Servier, Romania; Servier, Russian Federation


  • Trastal
    Servier, China


  • Trivastal Retard
    Servier, Brazil; Servier, Malta; Servier, Vietnam


  • Trivastal
    Serdia, India; Servier, United Arab Emirates; Servier, Netherlands Antilles; Servier, Argentina; Servier, Aruba; Servier, Barbados; Servier, Bahrain; Servier, Bermuda; Servier, Bahamas; Servier, Egypt; Servier, France; Servier, Grenada; Servier, Guyana; Servier, Iraq; Servier, Jamaica; Servier, Jordan; Servier, Kuwait; Servier, Cayman Islands; Servier, Lebanon; Servier, Saint Lucia; Servier, Luxembourg; Servier, Malta; Servier, Malaysia; Servier, Oman; Servier, Philippines; Servier, Portugal; Servier, Qatar; Servier, Saudi Arabia; Servier, Singapore; Servier, Syria; Servier, Thailand; Servier, Tunisia; Servier, Turkey; Servier, Trinidad & Tobago; Servier, Saint Vincent & The Grenadines; Servier, Venezuela; Servier, Yemen


  • Trivastan
    Servier-F, Italy


  • Trivastal
    Servier, France; Servier, Oman

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 2 December 2010

Desenex Spray


Pronunciation: mi-KON-a-zole
Generic Name: Miconazole
Brand Name: Examples include Lotrimin AF and Micatin


Desenex Spray is used for:

Treating athlete's foot, jock itch, or ringworm and relieving the itching, scaling, burning, and discomfort due to those conditions. It may also be used for other conditions as determined by your doctor.


Desenex Spray is an antifungal. It works by weakening the fungal cell membrane, which kills the fungus.


Do NOT use Desenex Spray if:


  • you are allergic to any ingredient in Desenex Spray

Contact your doctor or health care provider right away if any of these apply to you.



Before using Desenex Spray:


Some medical conditions may interact with Desenex Spray. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Desenex Spray. Because little, if any, of Desenex Spray is absorbed into the blood, the risk of it interacting with another medicine is low.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Desenex Spray may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Desenex Spray:


Use Desenex Spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Shake can well before using.

  • Clean the affected area and dry it thoroughly.

  • Hold can about 6 inches from the area to be treated and spray a thin layer of medicine over the affected area in the morning and at night or as directed by your doctor.

  • Wash hands immediately after using Desenex Spray unless your hands are part of the treated area.

  • For athlete's foot, pay special attention to the areas between the toes. Wear well-fitting, ventilated shoes, and change your shoes and socks at least once daily.

  • To clear up your infection completely, continue using Desenex Spray for the full course of treatment even if you feel better in a few days.

  • Supervise children in the use of this product.

  • If you miss a dose of Desenex Spray, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Desenex Spray.



Important safety information:


  • Desenex Spray is for external use only. Avoid contact with the eyes. If you get Desenex Spray in your eyes, rinse them immediately with a generous amount of cool water.

  • Avoid inhaling the vapors of Desenex Spray.

  • If Desenex Spray is swallowed, contact a doctor or poison control center immediately.

  • Desenex Spray is flammable. Do not store or use near fire or other open flame. Do not use while smoking.

  • Do not puncture or burn the container.

  • Do not cover the treated area with a bandage or dressing unless directed otherwise by your doctor.

  • If there is no improvement of athlete's foot or ringworm within 4 weeks or jock itch within 2 weeks, or if your condition persists, contact your health care provider.

  • Desenex Spray is not effective on the scalp or nails.

  • Do not use on CHILDREN younger than 2 years of age unless directed by a doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Desenex Spray, discuss with your doctor the benefits and risks of using Desenex Spray during pregnancy. It is unknown if Desenex Spray is excreted in breast milk. If you are or will be breast-feeding while you are using Desenex Spray, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Desenex Spray:


All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); irritation.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Desenex Spray:

Store Desenex Spray at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Avoid temperatures above 120 degrees F (49 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Desenex Spray out of the reach of children and away from pets.


General information:


  • If you have any questions about Desenex Spray, please talk with your doctor, pharmacist, or other health care provider.

  • Desenex Spray is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Desenex Spray. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Desenex resources


  • Desenex Use in Pregnancy & Breastfeeding
  • Desenex Drug Interactions
  • 0 Reviews for Desenex - Add your own review/rating


  • Desenex Spray Concise Consumer Information (Cerner Multum)

  • Absorbine Jr. Antifungal Topical Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Desenex with other medications


  • Tinea Corporis
  • Tinea Pedis